Literature DB >> 17846117

Delineation of species-specific binding properties of the CspZ protein (BBH06) of Lyme disease spirochetes: evidence for new contributions to the pathogenesis of Borrelia spp.

Elizabeth A Rogers1, Richard T Marconi.   

Abstract

Borrelia burgdorferi CspZ (TIGR open reading frame designation, BBH06) is part of a functionally related group of proteins that bind one or more members of the factor H (FH) protein family. In this report we assess the conservation, distribution, properties, and ligand binding abilities of CspZ from the three main Borrelia species associated with Lyme disease infections in humans. CspZ (also referred to as BbCRASP-2 in the literature) was found to be highly conserved at the intraspecies level but divergent at the interspecies level. All CspZ orthologs that originated from B. burgdorferi isolates bound FH from a diverse group of mammals. In contrast, CspZ derived from B. garinii and B. afzelii did not. Regardless of the Borrelia species of origin, all CspZ proteins tested bound to unknown approximately 60-kDa serum proteins produced by different mammals. To further define the molecular basis for the differential binding of CspZ orthologs to host proteins, DNA sequence, truncation, and site-directed mutagenesis analyses were performed. DNA sequence analyses revealed that B. garinii and B. afzelii CspZ orthologs possess a 64-amino-acid N-terminal domain that is absent from B. burgdorferi CspZ. However, binding analyses of recombinant proteins revealed that this domain does not in and of itself influence ligand binding properties. Truncation and mutagenesis analyses further revealed that the key determinants required for ligand binding are discontinuous and that the presentation of the ligand binding pocket is dependent on alpha helices with high coiled-coil formation probability. The data presented here provide insight into the molecular basis of CspZ-ligand interactions and suggest that CspZ orthologs from diverse Borrelia species can contribute to the host-pathogen interaction through their interaction with serum proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17846117      PMCID: PMC2168308          DOI: 10.1128/IAI.00850-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with Borrelia burgdorferi and in human lyme disease patients.

Authors:  P Scott Hefty; Chad S Brooks; Amy M Jett; Gary L White; Stephen K Wikel; Ronald C Kennedy; Darrin R Akins
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Correlation between plasmid content and infectivity in Borrelia burgdorferi.

Authors:  J E Purser; S J Norris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes.

Authors:  Brian Stevenson; Nazira El-Hage; Melissa A Hines; Jennifer C Miller; Kelly Babb
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi.

Authors:  J Hellwage; T Meri; T Heikkilä; A Alitalo; J Panelius; P Lahdenne; I J Seppälä; S Meri
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

5.  Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H.

Authors:  P Kraiczy; C Skerka; M Kirschfink; V Brade; P F Zipfel
Journal:  Eur J Immunol       Date:  2001-06       Impact factor: 5.532

6.  Analysis of mechanisms associated with loss of infectivity of clonal populations of Borrelia burgdorferi B31MI.

Authors:  J V McDowell; S Y Sung; M Labandeira-Rey; J T Skare; R T Marconi
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation.

Authors:  A Alitalo; T Meri; L Rämö; T S Jokiranta; T Heikkilä; I J Seppälä; J Oksi; M Viljanen; S Meri
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  Immune evasion of Borrelia burgdorferi: mapping of a complement-inhibitor factor H-binding site of BbCRASP-3, a novel member of the Erp protein family.

Authors:  Peter Kraiczy; Jens Hellwage; Christine Skerka; Michael Kirschfink; Volker Brade; Peter F Zipfel; Reinhard Wallich
Journal:  Eur J Immunol       Date:  2003-03       Impact factor: 5.532

9.  Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs.

Authors:  Antti Alitalo; Taru Meri; Hilkka Lankinen; Ilkka Seppälä; Pekka Lahdenne; P Scott Hefty; Darrin Akins; Seppo Meri
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

10.  Dual binding specificity of a Borrelia hermsii-associated complement regulator-acquiring surface protein for factor H and plasminogen discloses a putative virulence factor of relapsing fever spirochetes.

Authors:  Evelyn Rossmann; Peter Kraiczy; Pia Herzberger; Christine Skerka; Michael Kirschfink; Markus M Simon; Peter F Zipfel; Reinhard Wallich
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

View more
  33 in total

1.  Rrp1, a cyclic-di-GMP-producing response regulator, is an important regulator of Borrelia burgdorferi core cellular functions.

Authors:  Elizabeth A Rogers; Darya Terekhova; Hong-Ming Zhang; Kelley M Hovis; Ira Schwartz; Richard T Marconi
Journal:  Mol Microbiol       Date:  2009-01-23       Impact factor: 3.501

2.  Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts.

Authors:  Ashley L Marcinkiewicz; Alan P Dupuis; Maxime Zamba-Campero; Nancy Nowak; Peter Kraiczy; Sanjay Ram; Laura D Kramer; Yi-Pin Lin
Journal:  Cell Microbiol       Date:  2019-01-07       Impact factor: 3.715

3.  Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection.

Authors:  Eric H Weening; Nikhat Parveen; Jerome P Trzeciakowski; John M Leong; Magnus Höök; Jonathan T Skare
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

4.  The BBA33 lipoprotein binds collagen and impacts Borrelia burgdorferi pathogenesis.

Authors:  Hui Zhi; Eric H Weening; Elena Magda Barbu; Jenny A Hyde; Magnus Höök; Jon T Skare
Journal:  Mol Microbiol       Date:  2015-01-30       Impact factor: 3.501

5.  Identification and functional characterisation of Complement Regulator Acquiring Surface Protein-1 of serum resistant Borrelia garinii OspA serotype 4.

Authors:  Nathalie D van Burgel; Peter Kraiczy; Tim J Schuijt; Peter F Zipfel; Alje P van Dam
Journal:  BMC Microbiol       Date:  2010-02-10       Impact factor: 3.605

6.  Identification of an antiparallel coiled-coil/loop domain required for ligand binding by the Borrelia hermsii FhbA protein: additional evidence for the role of FhbA in the host-pathogen interaction.

Authors:  Kelley M Hovis; John C Freedman; Hongming Zhang; Jonathan L Forbes; Richard T Marconi
Journal:  Infect Immun       Date:  2008-02-25       Impact factor: 3.441

7.  Comparative analysis of the properties and ligand binding characteristics of CspZ, a factor H binding protein, derived from Borrelia burgdorferi isolates of human origin.

Authors:  Elizabeth A Rogers; Shane V Abdunnur; John V McDowell; Richard T Marconi
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

8.  Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease.

Authors:  Peter Kraiczy; Annekatrin Seling; Catherine A Brissette; Evelyn Rossmann; Klaus-Peter Hunfeld; Tomasz Bykowski; Logan H Burns; Matthew J Troese; Anne E Cooley; Jennifer C Miller; Volker Brade; Reinhard Wallich; Sherwood Casjens; Brian Stevenson
Journal:  Clin Vaccine Immunol       Date:  2007-12-26

Review 9.  Borrelia burgdorferi complement regulator-acquiring surface proteins (BbCRASPs): Expression patterns during the mammal-tick infection cycle.

Authors:  Tomasz Bykowski; Michael E Woodman; Anne E Cooley; Catherine A Brissette; Reinhard Wallich; Volker Brade; Peter Kraiczy; Brian Stevenson
Journal:  Int J Med Microbiol       Date:  2007-12-31       Impact factor: 3.473

10.  Analysis of a growth-phase-regulated two-component regulatory system in the periodontal pathogen Treponema denticola.

Authors:  Jesse R Frederick; Elizabeth A Rogers; Richard T Marconi
Journal:  J Bacteriol       Date:  2008-07-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.